Colorectal cancer laboratory news

8 Sep 2017

The science news portal Madri+d echoes on the release of the video “Meet Our Scientists” about the research into colon cancer conducted by Eduard Batlle, ICREA researcher at IRB Barcelona.

The Madri+d news bulletin reaches more than 60,000 subscribers.

Link to Madri+d

<p>The video "Decostructing colon cancer", the tenth video in the series "Meet Our Scientists", presents the work performed by Eduard Batlle, who leads the Colorectal Cancer laboratory at IRB Barcelona</p>
31 Jul 2017

ICREA research professor Eduard Batlle is featured in the “Meet Our Scientists” video entitled “Deconstructing colon cancer”.

The video presents IRB Barcelona's Colorectal Cancer Laboratory research, which is devoted to understanding the behaviour of colon tumours and propose new cures for patients.

<p>Eduard Batlle.</p>
13 Jun 2017

The newspaper "ARA" reports on the award of the XI Francisco Cobos Foundation Prize for Excellence in Biomedical Research to ICREA researcher Eduard Batlle, coordinator of the Oncology Programme and head of the Colorectal Cancer Laboratory at IRB Barcelona.

The article also includes the jury's acknowledgment of his contribution to knowledge of colorectal cancer and the potential of his research to generate new treatments and diagnostic tools for this disease.

Selected Media Mentions 

Link to Diari ARA

Link to...

<p>Eduard Batlle heads the Colorectal Cancer Laboratory at the IRB Barcelona</p>
13 Jun 2017

The foundation, which is based in Madrid, awards Batlle for his research of excellence on colon cancer—one of the tumours with greatest prevalence worldwide.The foundation, which is based in Madrid, awards Batlle for his research of excellence on colon cancer—one of the tumours with greatest prevalence worldwide.

<p>Picture of a colon tumour (Author: Eduard Batlle, IRB).</p>
8 May 2017

The project, headed by group leader and ICREA researcher Eduard Batlle, receives a 60,000-€ grant.

The study will test the effectiveness of immunotherapies to treat metastatic disease in advanced colorectal cancer.

Research will take place during the academic years 2017 and 2018.

 

<p>Open Day 2015.</p>
8 May 2017

On May 13, IRB Barcelona will be holding its Open Day, from 10:00 to 15:00, and almost all the places have been reserved.

Audiences of all ages will visit the laboratories, participate in workshops, and attend informative talks at the Institute, which is located in the Barcelona Science Park.

<p>Patient derived colorectal cancer in mice with LGR5-enhanced flourescent protein (EGFP) modification to follow the behaviour of cancer stem cells (image: G. Turon, IRB Barcelona)</p>
3 May 2017

In EMBO Molecular Medicine, IRB Barcelona scientists report a technique based on a combination of CRISPR/Cas9 genome editing and patient-derived tumour organoids that allows the study of cell heterogeneity in human tumours.

The novel approach was used to examine the behaviour of colorectal cancer stem cells by tracing specific marker genes.

<p>This TECNIO seal recognises the IRB Barcelona's Innovation department as a competitive agent in Catalonia’s innovation system</p>
24 Apr 2017

ACCIÓ awards the Institute’s Innovation Department with the quality seal TECNIO and two VALUNI grants for technology transfer projects

<p>Copyright: Getty Images.</p>
2 Apr 2017

The Huffington Post publishes an extensive report on cancer-causing mutations, with a special focus on random DNA errors that occur when self-renewing cells divide, according to a recent paper published in Science by researchers at Johns Hopkins University. 

The report includes declarations of several experts on cancer studies, among them IRB Barcelona research associates Elena Sancho, in the Colorectal Cancer Lab, and Gloria Pascual, in the Stem Cells and Cancer Lab. "Does this means that we can do as we please because whatever we do, we'll have the same probability of having cancer? The answer is a resounding no", stresses Elena Sancho. 

Link to ...

20 Mar 2017

The 2017 Issue of the European Biotechnology magazine on the Life Sciences and Industry features recent studies conducted at IRB Barcelona by Oriol Gallego, research associate with the Translational Control of Cell Cycle and Differentiation Lab, and Salvador Aznar Benitah, ICREA researcher and group leader of the Stem Cells and Cancer Lab.

The magazines also includes a news piece about the research collaboration between Eduard Batlle's laboratory and the clinical-stage immuno-oncology company devoted to innovative bispecific antibody therapeutics Merus N.V., to develop antibodies targeting the tumour microenvironment.

Link to...